scholarly journals Laparoscopic right hepatectomy after portal vein embolization in hepatocellular carcinoma

2021 ◽  
Vol 25 (1) ◽  
pp. S248-S248
Author(s):  
Jaryung HAN ◽  
Young Seok HAN
Keyword(s):  
Hepatocellular Carcinoma ◽  
Portal Vein ◽  
Portal Vein Embolization ◽  
Right Hepatectomy ◽  
Laparoscopic Right Hepatectomy

scholarly journals Laparoscopic right hepatectomy following right portal vein embolization for hepatocellular carcinoma

HPB ◽  
2018 ◽  
Vol 20 ◽  
pp. S117
Author(s):  
K.P. MacCallum ◽  
A. Chokechanachaisakul ◽  
J.A. Graham ◽  
S. Bellemare ◽  
M.M. Kinkhabwala ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Portal Vein ◽  
Portal Vein Embolization ◽  
Right Hepatectomy ◽  
Laparoscopic Right Hepatectomy

scholarly journals Robotic right hepatectomy for hepatocellular carcinoma after portal vein embolization

HPB ◽  
2019 ◽  
Vol 21 ◽  
pp. S93
Author(s):  
I. Sucandy ◽  
J.D. Spence ◽  
S.B. Ross ◽  
A.S. Rosemurgy
Keyword(s):  
Hepatocellular Carcinoma ◽  
Portal Vein ◽  
Portal Vein Embolization ◽  
Right Hepatectomy

Laparoscopic Right Hepatectomy Extended to Middle Hepatic Vein After Right Portal Vein Embolization

2013 ◽  
Vol 21 (1) ◽  
pp. 165-166 ◽  
Author(s):  
Fernando Rotellar ◽  
Fernando Pardo ◽  
Alberto Benito ◽  
Pablo Martí-Cruchaga ◽  
Gabriel Zozaya ◽  
...  
Keyword(s):  
Portal Vein ◽  
Hepatic Vein ◽  
Portal Vein Embolization ◽  
Middle Hepatic Vein ◽  
Right Hepatectomy ◽  
Laparoscopic Right Hepatectomy

Multiple utilities of portal vein embolization for patients with hepatocellular carcinoma.

2012 ◽  
Vol 30 (4_suppl) ◽  
pp. 319-319
Author(s):  
Toru Beppu ◽  
Hirohisa Okabe ◽  
Kazutoshi Okabe ◽  
Toshiro Masuda ◽  
Kosuke Mima ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Overall Survival ◽  
Portal Vein ◽  
Portal Vein Embolization ◽  
Liver Volume ◽  
Disease Free Survival ◽  
Remnant Liver ◽  
Right Hepatectomy ◽  
Tace Group ◽  
Disease Free

319 Background: Portal vein embolization (PVE) is a multi-potential treatment for hepatocellular carcinoma (HCC). The aim of this study is to identify the efficacies of PVE for resectable and unresectable HCC patients. Methods: Until 2011, 668 HCC patients underwent hepatic resection and 102 HCC patients treated with PVE. PVE was performed with percutaneous and ipsilateral approach using ethanolamine oleate iopamidol. Preoperative future remnant liver volume (%LV) and functional liver volume (%FLV ) were assessed with our developed combined 99mTc- galactosyl human serum albumin (GSA) scintigraphy (SPECT)/CT system. In unresectable cases chemoembolization (TACE) was repeated after PVE. Results: 1. Comparison of %LV and %FLV after right-PVE (n=40). %FLV before PVE was significantly lower in PVE group (38%) compared to non-PVE group (58%), but increased remarkably after PVE (from 38% to 55%, P < 0.0001). Right hepatectomy was successfully completed in 10 patients based on %FLV, instead of conventional %LV. 2. Long-term prognosis after right-hepatectomy with /without PVE (n=60). The 3- and 5-year disease-free survival (DFS) rates in the PVE group were significantly greater than those in the non-PVE group (78% and 78% versus 20% and 0%, P = 0.01). The 3- and 5-year overall survival (OS) rates in the PVE group were also higher than those in the non-PVE group (72% and 72% versus 57% and 12%, P <0.05). By multivariate analysis, independent prognostic factors for DFS were application of PVE (HR3.59), Multiple tumor (HR3.57), Fibrosis stage F3–4 (HR2.81), and protein induced by vitamin K absence or antagonists-II (PIVKA-II) ≥678AU/ml (HR2.69). 3. Prevention of intrahepatic metastases in unresectable HCCs in hemi-liver (n=40). The 3-year intrahepatic recurrence rates in the non-portal-embolized area was 58.8% and 81.8%, and the 5-year OS was 38.2% and 8.5%, in the PVE/TACE group and TACE group, respectively. The former rates were sinificantly higher (P<0.05). Conclusions: PVE can improve resectability, and might improve disease-free and overall survival for patients with both resectable and unresectable HCC.

Robotic Right Hepatectomy—for Hepatocellular Carcinoma Requiring Preoperative Portal Vein Embolization

2020 ◽  
pp. 000313482095635
Author(s):  
Iswanto Sucandy ◽  
Janelle Spence ◽  
Sharona Ross ◽  
Alexander Rosemurgy
Keyword(s):  
Hepatocellular Carcinoma ◽  
Portal Vein ◽  
Portal Vein Embolization ◽  
Right Hepatectomy

scholarly journals Laparoscopic right hepatectomy and distal MHV resection after portal vein embolization for intraductal papillary neoplasm of bile duct

HPB ◽  
2019 ◽  
Vol 21 ◽  
pp. S214-S215
Author(s):  
Wipusit Taesombat ◽  
Athaya Vorasitta ◽  
Methee Sutherasan ◽  
Bunthoon Nonthasoot ◽  
Boonchoo Sirichindakul
Keyword(s):  
Bile Duct ◽  
Portal Vein ◽  
Portal Vein Embolization ◽  
Right Hepatectomy ◽  
Intraductal Papillary Neoplasm ◽  
Laparoscopic Right Hepatectomy ◽  
Papillary Neoplasm
Sign in / Sign up

Export Citation Format

Share Document